Publication | Open Access
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial
113
Citations
31
References
2017
Year
Lymphoid NeoplasiaRefractory HodgkinMedicinePathologyCancer TreatmentOncologyRadiation OncologyBrentuximab Vedotin
| Year | Citations | |
|---|---|---|
Page 1
Page 1